Menu
1 min read · estimated
APPROVED USE
What FDA approved
For adults with metastatic or recurrent locally advanced Merkel cell carcinoma.
LAMPGEN ANALYSIS
Why it matters
FDA records traditional approval of the original 2023 accelerated Merkel cell indication, distinct from the 2025 anal cancer uses.
What research teams should watch
Preserve the Merkel cell evidence and label as a separate line in the indication tracker and route referrals through the rare skin tumor service.
PRIMARY RECORDS